Sandra Parra

1.5k total citations
36 papers, 782 citations indexed

About

Sandra Parra is a scholar working on Emergency Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, Sandra Parra has authored 36 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Emergency Medicine, 10 papers in Surgery and 9 papers in Infectious Diseases. Recurrent topics in Sandra Parra's work include HIV-related health complications and treatments (12 papers), Systemic Lupus Erythematosus Research (8 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). Sandra Parra is often cited by papers focused on HIV-related health complications and treatments (12 papers), Systemic Lupus Erythematosus Research (8 papers) and Atherosclerosis and Cardiovascular Diseases (7 papers). Sandra Parra collaborates with scholars based in Spain, Netherlands and United States. Sandra Parra's co-authors include Carlos Alonso‐Villaverde, Blai Coll, L. Masana, Jorge Joven, Gerard Aragonès, Jordi Camps, Manuel Montero, Mònica Tous, Antoni Castro and Judit Marsillach and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Stroke.

In The Last Decade

Sandra Parra

34 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Parra Spain 16 347 208 198 171 137 36 782
James Dressman United States 7 202 0.6× 132 0.6× 104 0.5× 149 0.9× 73 0.5× 8 486
Benvenuto Grisorio Italy 19 360 1.0× 188 0.9× 295 1.5× 221 1.3× 42 0.3× 27 1.2k
Andrea Bedynek Germany 10 79 0.2× 42 0.2× 57 0.3× 279 1.6× 175 1.3× 10 713
Fernando Alegre Spain 12 84 0.2× 132 0.6× 133 0.7× 78 0.5× 101 0.7× 15 984
Meghan N. Feldpausch United States 13 211 0.6× 75 0.4× 77 0.4× 114 0.7× 21 0.2× 30 599
Sarah L. Fishman United States 7 53 0.2× 33 0.2× 46 0.2× 32 0.2× 28 0.2× 12 581
Martin Kummen Norway 18 41 0.1× 29 0.1× 132 0.7× 318 1.9× 73 0.5× 28 1.1k
Jacqueline Capeau France 11 148 0.4× 64 0.3× 77 0.4× 143 0.8× 8 0.1× 14 559
Jolene Kay Berg United States 13 18 0.1× 42 0.2× 170 0.9× 174 1.0× 69 0.5× 25 788
P A Batman United Kingdom 15 125 0.4× 151 0.7× 122 0.6× 110 0.6× 42 0.3× 21 616

Countries citing papers authored by Sandra Parra

Since Specialization
Citations

This map shows the geographic impact of Sandra Parra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Parra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Parra more than expected).

Fields of papers citing papers by Sandra Parra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Parra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Parra. The network helps show where Sandra Parra may publish in the future.

Co-authorship network of co-authors of Sandra Parra

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Parra. A scholar is included among the top collaborators of Sandra Parra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Parra. Sandra Parra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pujol, Isabel, Simona Iftimie, Jordi Camps, et al.. (2025). Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia. Chemico-Biological Interactions. 418. 111606–111606.
2.
Saballs, Mireia, Sandra Parra, Núria Amigó, et al.. (2024). Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia. Journal of Lipid Research. 65(9). 100622–100622. 9 indexed citations
3.
Iftimie, Simona, Núria Amigó, Neus Martínez-Micaelo, et al.. (2024). Differential analysis of lipoprotein and glycoprotein profiles in bacterial infections and COVID-19 using proton nuclear magnetic resonance and machine learning. Heliyon. 10(17). e37115–e37115. 1 indexed citations
4.
Parra, Sandra, Mireia Saballs, Mark J. DiNubile, et al.. (2023). Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease. SHILAP Revista de lepidopterología. 52. 1–8. 7 indexed citations
5.
Saballs, Mireia, Sandra Parra, M. Feliu, et al.. (2016). HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia. SpringerPlus. 5(1). 1491–1491. 13 indexed citations
6.
Parra, Sandra, Antoni Castro, & L. Masana. (2014). The pleiotropic role of HDL in autoimmune diseases. Clínica e Investigación en Arteriosclerosis. 27(2). 97–106. 12 indexed citations
7.
Parra, Sandra, Raimón Ferré, Marta Domínguez‐Gil González, et al.. (2012). Complement system and small HDL particles are associated with subclinical atherosclerosis in SLE patients. Atherosclerosis. 225(1). 224–230. 32 indexed citations
8.
Parra, Sandra, Judit Marsillach, Gerard Aragonès, et al.. (2010). Paraoxonase‐1 Gene Haplotypes Are Associated with Metabolic Disturbances, Atherosclerosis, and Immunologic Outcome in HIV‐Infected Patients. The Journal of Infectious Diseases. 201(4). 627–634. 23 indexed citations
9.
10.
Coll, Blai, Sandra Parra, Carlos Alonso‐Villaverde, et al.. (2007). The Role of Immunity and Inflammation in the Progression of Atherosclerosis in Patients With HIV Infection. Stroke. 38(9). 2477–2484. 50 indexed citations
11.
Coll, Blai, Anna Cabré, Carlos Alonso‐Villaverde, et al.. (2007). The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis. 199(1). 147–153. 32 indexed citations
12.
Coll, Blai, J.P.H. van Wijk, Sandra Parra, et al.. (2006). Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy. European Journal of Pharmacology. 544(1-3). 104–110. 35 indexed citations
13.
Joven, Jorge, Blai Coll, Mònica Tous, et al.. (2006). The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis. Clinica Chimica Acta. 368(1-2). 114–119. 32 indexed citations
14.
Coll, Blai, Carlos Alonso‐Villaverde, Sandra Parra, et al.. (2006). Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor‐based antiretroviral therapy. HIV Medicine. 7(6). 356–360. 6 indexed citations
15.
Coll, Blai, Sandra Parra, Carlos Alonso‐Villaverde, et al.. (2006). HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: The role of monocyte chemoattractant protein-1. Cytokine. 34(1-2). 51–55. 39 indexed citations
16.
Coll, Blai, Gerard Aragonès, Sandra Parra, Carlos Alonso‐Villaverde, & L. Masana. (2006). Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients. AIDS. 20(12). 1675–1677. 48 indexed citations
17.
Guardiola, Montse, Raimón Ferré, Juliana Salazar, et al.. (2006). Protease Inhibitor-Associated Dyslipidemia in HIV-Infected Patients Is Strongly Influenced by the APOA5–1131T→C Gene Variation. Clinical Chemistry. 52(10). 1914–1919. 39 indexed citations
18.
Parra, Sandra, Carlos Alonso‐Villaverde, Blai Coll, et al.. (2006). Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection. Atherosclerosis. 194(1). 175–181. 57 indexed citations
19.
Coll, Blai, Carlos Alonso‐Villaverde, Sandra Parra, et al.. (2005). The stromal derived factor-1 mutated allele (SDF1-3′A) is associated with a lower incidence of atherosclerosis in HIV-infected patients. AIDS. 19(16). 1877–1883. 17 indexed citations
20.
Alonso‐Villaverde, Carlos, et al.. (2003). High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy. AIDS. 17(8). 1173–1178. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Dressman Breakdown of academic impact, for papers by Benvenuto Grisorio Breakdown of academic impact, for papers by Andrea Bedynek Breakdown of academic impact, for papers by Fernando Alegre Breakdown of academic impact, for papers by Meghan N. Feldpausch Breakdown of academic impact, for papers by Sarah L. Fishman Breakdown of academic impact, for papers by Martin Kummen Breakdown of academic impact, for papers by Jacqueline Capeau Breakdown of academic impact, for papers by Jolene Kay Berg Breakdown of academic impact, for papers by P A Batman
Rankless by CCL
2026